BRIEF published on 08/05/2024 at 13:34, 2 years 1 month ago Continental AG Evaluates Spin-Off of Automotive Group Sector Shareholders Frankfurt Stock Exchange Strategic Review Continental AG Automotive Spin-off
BRIEF published on 08/05/2024 at 13:34, 2 years 1 month ago Continental AG évalue la scission du secteur du groupe automobile Actionnaires Bourse De Francfort Revue Stratégique Continental SA Spin-off Automobile
BRIEF published on 08/05/2024 at 13:08, 2 years 1 month ago Adesso SE Reports Strong Sales Growth in H1 2024 EBITDA Sales Growth Digitalization Financial Forecast Capacity Utilization
BRIEF published on 08/05/2024 at 13:08, 2 years 1 month ago Adesso SE annonce une forte croissance de ses ventes au premier semestre 2024 Prévisions Financières Numérisation BAIIA La Croissance Des Ventes Capacité D'utilisation
BRIEF published on 08/05/2024 at 13:06, 2 years 1 month ago Cenit AG: GBC AG Recommends 'BUY' with Raised Target Price Acquisition US Market Target Price Sales Forecast EBIT Growth
BRIEF published on 08/05/2024 at 13:06, 2 years 1 month ago Cenit AG : GBC AG recommande « ACHETER » avec un prix cible augmenté Acquisition Marché Américain Croissance De L'EBIT Prix Indicatif Prévisions De Ventes
BRIEF published on 08/05/2024 at 13:05, 2 years 1 month ago Revir Technologies and Tyler Technologies Partner on Digital Evidence Partnership Compliance Cloud Infrastructure Digital Evidence Justice Agencies
BRIEF published on 08/05/2024 at 13:05, 2 years 1 month ago Revir Technologies et Tyler Technologies s'associent sur les preuves numériques Partenariat Conformité Infrastructure Cloud Preuve Numérique Agences Judiciaires
BRIEF published on 08/05/2024 at 13:05, 2 years 1 month ago Electrovaya Announces Date for Q3-2024 Financial Results & Conference Call Financial Results Conference Call Electrovaya Q3 2024 Investor Update Date: Tuesday, August 13, 2024 Time: 5:00 P.m. ET Toll-Free: 877-545-0523 International: 973-528-0016 Participant Access Code: 302979
BRIEF published on 08/05/2024 at 13:05, 2 years 1 month ago Electrovaya annonce la date des résultats financiers du troisième trimestre 2024 et une conférence téléphonique Résultats Financiers Conférence Téléphonique Electrovaya Le Point Sur Les Investisseurs T3 2024 Date : Mardi 13 Août 2024 Heure : 17 H HE Sans Frais : 877-545-0523 International : 973-528-0016 Code D'accès Participants : 302979
Published on 09/11/2026 at 04:00, 8 hours 21 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 56 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 1 minute ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 21 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 38 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 45 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 51 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 6 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 21 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 21 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 21 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 51 minutes ago Availability of the 2026 Interim Financial Report
